“We are thrilled to be included in the Standard List,” said Shivang Dave, PlenOptika CEO and one of QuickSee’s inventors. “As a leading organization in the fight to prevent blindness and improve eye health, IAPB’s evaluation of QuickSee as a trustworthy tool is both gratifying and humbling. We are confident this will help us provide millions more people with fast, clinically accurate, and accessible autorefraction.”
The Standard List has been a trusted resource for NGOs, government agencies, and other nonprofits to help them select and procure the equipment they need for eye care initiatives. To become included as a Valued Supplier, organizations must pass a rigorous evaluation of the quality of their company, products, and processes and demonstrate strong alignment with the IAPB mission.
Invented to meet the global challenge of poor vision
Designers searching for solutions to the global burden of poor vision invented QuickSee at the Massachusetts Institute of Technology. Finding that almost one billion people suffer poor vision that could be corrected by affordable eyeglasses, they set about discovering what roadblocks stood in the way.
They soon found that while eyeglasses were accessible, accurate prescriptions for them were not. High quality refraction is a bottleneck in many parts of the world, requiring expensive equipment and highly trained professionals unable to meet the sheer volume of the patient need. PlenOptika’s founders decided to focus on improving this key step in the prescription process.
The listing for QuickSee notes its accuracy—producing measurements within 0.5D in more than 85% of patients and 0.25D in 75% of patients—speed, rugged design, and accessibility. Each of these qualities were essential to meeting PlenOptika’s founding mission: to reduce the global burden of poor vision.